Senseonics Holdings, Inc. to Participate in the Stifel 2025 Healthcare Conference
Senseonics (NYSE American: SENS) will participate in the Stifel 2025 Healthcare Conference in New York on Wednesday, November 12, 2025. The company will take part in a fireside chat and hold one-on-one meetings at 4:40 PM ET. Interested parties may watch a live and recorded webcast via the company’s Investor Relations website at www.senseonics.com. The presentation provides management access for investors and analysts to discuss the company’s long-term implantable CGM systems and strategic outlook.
Senseonics (NYSE American: SENS) parteciperà al Stifel 2025 Healthcare Conference a New York mercoledì 12 novembre 2025. L'azienda interverrà in un fireside chat e terrà incontri individuali alle 16:40 ET. Gli interessati potranno seguire una trasmissione webcast in diretta e registrata tramite il sito della Relazioni con gli Investitori dell'azienda all'indirizzo www.senseonics.com. La presentazione offre agli investitori e agli analisti l'accesso al management per discutere i sistemi CGM impiantabili a lungo termine dell'azienda e le prospettive strategiche.
Senseonics (NYSE American: SENS) participará en la Conferencia de Salud Stifel 2025 en Nueva York el miércoles 12 de noviembre de 2025. La empresa participará en una conversación informal y realizará reuniones individuales a las 16:40 ET. Las personas interesadas pueden ver una retransmisión en vivo y grabada a través del sitio de Relaciones con Inversores de la empresa en www.senseonics.com. La presentación ofrece acceso de la dirección a inversores y analistas para discutir los sistemas CGM implantables a largo plazo de la empresa y su perspectiva estratégica.
Senseonics (NYSE American: SENS)은 뉴욕에서 개최되는 Stifel 2025 Healthcare Conference에 2025년 11월 12일 수요일에 참가합니다. 회사는 fireside chat에 참여하고 동부 표준시 기준 오후 4시 40분에 1:1 미팅을 가질 예정입니다. 관심 있는 분들은 회사의 투자자 관계 웹사이트인 www.senseonics.com에서 라이브 및 녹화된 웹캐스트를 시청할 수 있습니다. 이 프레젠테이션은 투자자와 애널리스트가 회사의 장기 이식 가능한 CGM 시스템과 전략적 전망에 대해 경영진과 논의할 수 있는 기회를 제공합니다.
Senseonics (NYSE American: SENS) participera à la Stifel 2025 Healthcare Conference à New York le mercredi 12 novembre 2025. L'entreprise participera à une conversation au coin du feu et tiendra des réunions individuelles à 16h40 ET. Les personnes intéressées peuvent regarder une webcast en direct et enregistrée via le site Investisseurs de l'entreprise à l'adresse www.senseonics.com. La présentation offre aux dirigeants un accès pour que les investisseurs et les analystes discutent des systèmes CGM implantables à long terme de l'entreprise et des perspectives stratégiques.
Senseonics (NYSE American: SENS) wird an der Stifel 2025 Healthcare Conference in New York am Mittwoch, dem 12. November 2025 teilnehmen. Das Unternehmen wird an einem fireside chat teilnehmen und um 16:40 Uhr ET Einzelgespräche führen. Interessierte können über die Investor Relations-Website des Unternehmens unter www.senseonics.com einen Live- und aufgezeichneten Webcast ansehen. Die Präsentation bietet den Managern Zugang für Investoren und Analysten, um über die langfristigen implantierbaren CGM-Systeme des Unternehmens und die strategische Ausrichtung zu sprechen.
سينسونيكز (NYSE American: SENS) ستشارك في مؤتمر ستيفل للرعاية الصحية 2025 في نيويورك يوم الأربعاء 12 نوفمبر 2025. ستشارك الشركة في جلسة Fireside chat وستعقد اجتماعات ثنائية فردية في الساعة 4:40 مساءً بتوقيت شرق الولايات المتحدة. يمكن للأطراف المهتمة مشاهدة بث حي وتسجيل عبر موقع العلاقات مع المستثمرين للشركة على www.senseonics.com. توفر هذه العروض للوصول إلى الإدارة للمستثمرين والمحللين لمناقشة أنظمة CGM القابلة للزرع على المدى الطويل والرؤية الاستراتيجية للشركة.
- None.
- None.
GERMANTOWN, Md., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced plans to participate in the upcoming Stifel 2025 Healthcare Conference, being held in New York, NY.
2025 Stifel Healthcare Conference
Format: Fireside chat and one-on-one meetings
Date: Wednesday, November 12, 2025
Time: 4:40 pm ET
Webcast: Click here
Interested parties may access a live and recorded webcast of the presentation on the “Investor Relations” section of the company’s website at www.senseonics.com.
About Senseonics
Senseonics Holdings, Inc. (“Senseonics”) is a medical technology company focused on the development and manufacturing of glucose monitoring products designed to transform lives in the global diabetes community with differentiated, long-term implantable glucose management technology. Senseonics' CGM systems Eversense® 365 and Eversense® E3 include a small sensor inserted completely under the skin that communicates with a smart transmitter worn over the sensor. The glucose data are automatically sent every 5 minutes to a mobile app on the user's smartphone.
Senseonics Investor Contact
Jeremy Feffer
LifeSci Advisors
investors@senseonics.com
FAQ
When will Senseonics (SENS) present at the Stifel 2025 Healthcare Conference?
How can investors watch the Senseonics (SENS) Stifel 2025 presentation?
What format will Senseonics (SENS) use at the Stifel 2025 Healthcare Conference?
What topics will Senseonics (SENS) likely cover at the Stifel 2025 Healthcare Conference?
Where is the Stifel 2025 Healthcare Conference being held for Senseonics (SENS)?
